Hormonotherapy

DRUG2 trials

Sponsors

UNICANCER, Centre Francois Baclesse

Conditions

Breast CancerMemory Disorders

Phase 3

Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment

CompletedNCT01564056

UNICANCERBreast Cancer

Start: 2012-04-12End: 2026-04-01Updated: 2026-07-20

Unknown Phase

Study of the Functioning of Prospective Memory in Breast Cancer and the Influence of Sleep

CompletedNCT03420105

Centre Francois BaclesseBreast Cancer, Memory Disorders

Start: 2018-01-05End: 2020-03-06Updated: 2020-03-09

Related Papers

Links between nocturnal hypoxia and cognitive function in breast cancer.

2025-11-27

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index (ASTER 70s): a randomised phase 3 trial.

2025-08-013 citations

Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study.

2018-09-037 citations